Learn more

QINGFA MA

Overview
  • Total Patents
    23
About

QINGFA MA has a total of 23 patent applications. Its first patent ever was published in 2007. It filed its patents most often in China. Its main competitors in its focus markets environmental technology are ONDREJMISKA KOLOMAN, CHANGZHOU YIJING LIGHT AND POWER TECHNOLOGY CO LTD and SHANGHAI PHARMATECH CO LTD.

Patent filings in countries

World map showing QINGFA MAs patent filings in countries
# Country Total Patents
#1 China 23

Patent filings per year

Chart showing QINGFA MAs patent filings per year from 1900 to 2020

Focus industries

Focus technologies

Top inventors

# Name Total Patents
#1 Qingfa Ma 23

Latest patents

Publication Filing date Title
CN101133838A Selenium germanium peptide bread
CN101133768A Nucleic acid tea
CN101103832A Schisandra chinensis nucleic acid beverage
CN101116522A Appetizing nucleic acid beverage
CN101352532A Six-grain liquor for stimulating appetite and lengthening life
CN101103769A Ammonia and Alcohol bovine nucleic acid feed
CN101103819A Selenium germanium peptide biscuit
CN101108199A Radical cure of sexual disorder with hexa- grain liquid appetising wood frog
CN101108004A Selenium germanium peptide sausage
CN101109002A Selenium germanium peptide tumor restraining wide mountain grape wine
CN101104030A Blood pressure reducing jujube tea paste for radically treating high blood pressure
CN101109003A Selenium germanium peptide anti-tumor liuliangye liquor
CN101081073A Selenium germanium peptide jujube tea paste for effecting radical cure of hepatitis B
CN101081072A Selenium germanium peptide jujube tea paste for effecting radical cure of sugar diabetes
CN101081075A Selenium germanium peptide jujube tea paste for effecting radical cure of tuberculosis, slow and fume
CN101081074A Selenium germanium peptide jujube tea paste for effecting radical cure of alimentary tract disease
CN101081238A Gene therapy for preventing and curing highly pathogenic bird flu and enteron disease
CN101254271A Gene therapy radically treating diabetes
CN101254240A Gene therapy for radically treating hepatitis B
CN101254233A Gene therapy for radical curing SARS respiratory disease